Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Sources of health information among U.S. cancer survivors: results from the health information national trends survey (HINTS).

AIMS public health

Jackson I, Osaghae I, Ananaba N, Etuk A, Jackson N, Chido-Amajuoyi OG.
PMID: 32617363
AIMS Public Health. 2020 Jun 12;7(2):363-379. doi: 10.3934/publichealth.2020031. eCollection 2020.

BACKGROUND: Health information is crucial for preservation of health and maintenance of healthy practices among cancer survivors. This study examines the sources and factors associated with choice of health information source among cancer survivors and those without a cancer...

Cite
Jackson I, Osaghae I, Ananaba N, et al. Sources of health information among U.S. cancer survivors: results from the health information national trends survey (HINTS). AIMS Public Health. 2020;7(2):363-379doi: 10.3934/publichealth.2020031.
Jackson, I., Osaghae, I., Ananaba, N., Etuk, A., Jackson, N., & Chido-Amajuoyi, O. G. (2020). Sources of health information among U.S. cancer survivors: results from the health information national trends survey (HINTS). AIMS public health, 7(2), 363-379. https://doi.org/10.3934/publichealth.2020031
Jackson, Inimfon, et al. "Sources of health information among U.S. cancer survivors: results from the health information national trends survey (HINTS)." AIMS public health vol. 7,2 (2020): 363-379. doi: https://doi.org/10.3934/publichealth.2020031
Jackson I, Osaghae I, Ananaba N, Etuk A, Jackson N, Chido-Amajuoyi OG. Sources of health information among U.S. cancer survivors: results from the health information national trends survey (HINTS). AIMS Public Health. 2020 Jun 12;7(2):363-379. doi: 10.3934/publichealth.2020031. eCollection 2020. PMID: 32617363; PMCID: PMC7327406.
Copy Download .nbib Format: NLM
Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018.

Pediatrics

Chido-Amajuoyi OG, Talluri R, Wonodi C, Shete S.
PMID: 33941585
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-012765. Epub 2021 May 03.

BACKGROUND AND OBJECTIVES: Routine human papillomavirus (HPV) vaccination is recommended at ages 11 to 12 years and may be initiated as early as 9 years of age.METHODS: Data were derived from the National Immunization Survey-Teen, spanning 2008-2018. Using health...

Cite
Chido-Amajuoyi OG, Talluri R, Wonodi C, et al. Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018. Pediatrics. 2021;147(6)doi: 10.1542/peds.2020-012765.
Chido-Amajuoyi, O. G., Talluri, R., Wonodi, C., & Shete, S. (2021). Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018. Pediatrics, 147(6), . https://doi.org/10.1542/peds.2020-012765
Chido-Amajuoyi, Onyema Greg, et al. "Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018." Pediatrics vol. 147,6 (2021). doi: https://doi.org/10.1542/peds.2020-012765
Chido-Amajuoyi OG, Talluri R, Wonodi C, Shete S. Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018. Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-012765. Epub 2021 May 03. PMID: 33941585.
Copy Download .nbib Format: NLM
Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017.

JAMA network open

Chido-Amajuoyi OG, Fueta P, Mantey D.
PMID: 33961039
JAMA Netw Open. 2021 May 03;4(5):e218060. doi: 10.1001/jamanetworkopen.2021.8060.

No abstract available.

Cite
Chido-Amajuoyi OG, Fueta P, Mantey D. Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017. JAMA Netw Open. 2021;4(5):e218060doi: 10.1001/jamanetworkopen.2021.8060.
Chido-Amajuoyi, O. G., Fueta, P., & Mantey, D. (2021). Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017. JAMA network open, 4(5), e218060. https://doi.org/10.1001/jamanetworkopen.2021.8060
Chido-Amajuoyi, Onyema Greg, et al. "Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017." JAMA network open vol. 4,5 (2021): e218060. doi: https://doi.org/10.1001/jamanetworkopen.2021.8060
Chido-Amajuoyi OG, Fueta P, Mantey D. Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017. JAMA Netw Open. 2021 May 03;4(5):e218060. doi: 10.1001/jamanetworkopen.2021.8060. PMID: 33961039; PMCID: PMC8105748.
Copy Download .nbib Format: NLM
Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019.

JAMA pediatrics

Chido-Amajuoyi OG, Talluri R, Shete SS, Shete S.
PMID: 34180965
JAMA Pediatr. 2021 Oct 01;175(10):1074-1076. doi: 10.1001/jamapediatrics.2021.1585.

No abstract available.

Cite
Chido-Amajuoyi OG, Talluri R, Shete SS, et al. Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019. JAMA Pediatr. 2021;175(10):1074-1076doi: 10.1001/jamapediatrics.2021.1585.
Chido-Amajuoyi, O. G., Talluri, R., Shete, S. S., & Shete, S. (2021). Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019. JAMA pediatrics, 175(10), 1074-1076. https://doi.org/10.1001/jamapediatrics.2021.1585
Chido-Amajuoyi, Onyema Greg, et al. "Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019." JAMA pediatrics vol. 175,10 (2021): 1074-1076. doi: https://doi.org/10.1001/jamapediatrics.2021.1585
Chido-Amajuoyi OG, Talluri R, Shete SS, Shete S. Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019. JAMA Pediatr. 2021 Oct 01;175(10):1074-1076. doi: 10.1001/jamapediatrics.2021.1585. PMID: 34180965; PMCID: PMC8240004.
Copy Download .nbib Format: NLM
Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017.

JAMA network open

Chido-Amajuoyi OG, Fueta P, Mantey D.
PMID: 33961039
JAMA Netw Open. 2021 May 03;4(5):e218060. doi: 10.1001/jamanetworkopen.2021.8060.

No abstract available.

Cite
Chido-Amajuoyi OG, Fueta P, Mantey D. Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017. JAMA Netw Open. 2021;4(5):e218060doi: 10.1001/jamanetworkopen.2021.8060.
Chido-Amajuoyi, O. G., Fueta, P., & Mantey, D. (2021). Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017. JAMA network open, 4(5), e218060. https://doi.org/10.1001/jamanetworkopen.2021.8060
Chido-Amajuoyi, Onyema Greg, et al. "Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017." JAMA network open vol. 4,5 (2021): e218060. doi: https://doi.org/10.1001/jamanetworkopen.2021.8060
Chido-Amajuoyi OG, Fueta P, Mantey D. Age at Smoking Initiation and Prevalence of Cigarette Use Among Youths in Sub-Saharan Africa, 2014-2017. JAMA Netw Open. 2021 May 03;4(5):e218060. doi: 10.1001/jamanetworkopen.2021.8060. PMID: 33961039; PMCID: PMC8105748.
Copy Download .nbib Format: NLM
Association of tobacco advertising, promotion and sponsorship (TAPS) exposure and cigarette use among Nigerian adolescents: implications for current practices, products and policies.

BMJ global health

Chido-Amajuoyi OG, Mantey DS, Clendennen SL, Pérez A.
PMID: 29082014
BMJ Glob Health. 2017 Aug 10;2(3):e000357. doi: 10.1136/bmjgh-2017-000357. eCollection 2017.

BACKGROUND: This study investigates the association between exposure to tobacco advertising, promotion and sponsorship (TAPS) and cigarette use behaviours among adolescents in five Nigerian regions. This is imperative given a 2015 WHO report on the global tobacco epidemic, revealing...

Cite
Chido-Amajuoyi OG, Mantey DS, Clendennen SL, et al. Association of tobacco advertising, promotion and sponsorship (TAPS) exposure and cigarette use among Nigerian adolescents: implications for current practices, products and policies. BMJ Glob Health. 2017;2(3):e000357doi: 10.1136/bmjgh-2017-000357.
Chido-Amajuoyi, O. G., Mantey, D. S., Clendennen, S. L., & Pérez, A. (2017). Association of tobacco advertising, promotion and sponsorship (TAPS) exposure and cigarette use among Nigerian adolescents: implications for current practices, products and policies. BMJ global health, 2(3), e000357. https://doi.org/10.1136/bmjgh-2017-000357
Chido-Amajuoyi, Onyema G, et al. "Association of tobacco advertising, promotion and sponsorship (TAPS) exposure and cigarette use among Nigerian adolescents: implications for current practices, products and policies." BMJ global health vol. 2,3 (2017): e000357. doi: https://doi.org/10.1136/bmjgh-2017-000357
Chido-Amajuoyi OG, Mantey DS, Clendennen SL, Pérez A. Association of tobacco advertising, promotion and sponsorship (TAPS) exposure and cigarette use among Nigerian adolescents: implications for current practices, products and policies. BMJ Glob Health. 2017 Aug 10;2(3):e000357. doi: 10.1136/bmjgh-2017-000357. eCollection 2017. PMID: 29082014; PMCID: PMC5656142.
Copy Download .nbib Format: NLM
Beliefs About HPV Vaccine's Success at Cervical Cancer Prevention Among Adult US Women.

JNCI cancer spectrum

Fokom Domgue J, Chido-Amajuoyi OG, Yu RK, Shete S.
PMID: 32280919
JNCI Cancer Spectr. 2019 Aug 27;3(4):pkz064. doi: 10.1093/jncics/pkz064. eCollection 2019 Dec.

BACKGROUND: Beliefs are known to be a key determinant in vaccines' uptake. However, little is known about beliefs surrounding the success of the human papillomavirus (HPV) vaccine in preventing cervical cancer in the United States.METHODS: Data from the Health...

Cite
Fokom Domgue J, Chido-Amajuoyi OG, Yu RK, et al. Beliefs About HPV Vaccine's Success at Cervical Cancer Prevention Among Adult US Women. JNCI Cancer Spectr. 2019;3(4):pkz064doi: 10.1093/jncics/pkz064.
Fokom Domgue, J., Chido-Amajuoyi, O. G., Yu, R. K., & Shete, S. (2019). Beliefs About HPV Vaccine's Success at Cervical Cancer Prevention Among Adult US Women. JNCI cancer spectrum, 3(4), pkz064. https://doi.org/10.1093/jncics/pkz064
Fokom Domgue, Joël, et al. "Beliefs About HPV Vaccine's Success at Cervical Cancer Prevention Among Adult US Women." JNCI cancer spectrum vol. 3,4 (2019): pkz064. doi: https://doi.org/10.1093/jncics/pkz064
Fokom Domgue J, Chido-Amajuoyi OG, Yu RK, Shete S. Beliefs About HPV Vaccine's Success at Cervical Cancer Prevention Among Adult US Women. JNCI Cancer Spectr. 2019 Aug 27;3(4):pkz064. doi: 10.1093/jncics/pkz064. eCollection 2019 Dec. PMID: 32280919; PMCID: PMC6901081.
Copy Download .nbib Format: NLM
School proximity and census tract correlates of e-cigarette specialty retail outlets (vape shops) in central Texas.

Preventive medicine reports

Chido-Amajuoyi OG, Ozigbu CE, Zhang K.
PMID: 32257777
Prev Med Rep. 2020 Mar 23;18:101079. doi: 10.1016/j.pmedr.2020.101079. eCollection 2020 Jun.

E-cigarettes are the most widely used tobacco product among middle and high school students in the United States. This study investigates the proximity of e-cigarette retail outlets (vape shops) to middle and high schools in Austin, Texas, as well...

Cite
Chido-Amajuoyi OG, Ozigbu CE, Zhang K. School proximity and census tract correlates of e-cigarette specialty retail outlets (vape shops) in central Texas. Prev Med Rep. 2020;18:101079doi: 10.1016/j.pmedr.2020.101079.
Chido-Amajuoyi, O. G., Ozigbu, C. E., & Zhang, K. (2020). School proximity and census tract correlates of e-cigarette specialty retail outlets (vape shops) in central Texas. Preventive medicine reports, 18101079. https://doi.org/10.1016/j.pmedr.2020.101079
Chido-Amajuoyi, Onyema Greg, et al. "School proximity and census tract correlates of e-cigarette specialty retail outlets (vape shops) in central Texas." Preventive medicine reports vol. 18 (2020): 101079. doi: https://doi.org/10.1016/j.pmedr.2020.101079
Chido-Amajuoyi OG, Ozigbu CE, Zhang K. School proximity and census tract correlates of e-cigarette specialty retail outlets (vape shops) in central Texas. Prev Med Rep. 2020 Mar 23;18:101079. doi: 10.1016/j.pmedr.2020.101079. eCollection 2020 Jun. PMID: 32257777; PMCID: PMC7115100.
Copy Download .nbib Format: NLM
Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018.

Pediatrics

Chido-Amajuoyi OG, Talluri R, Wonodi C, Shete S.
PMID: 33941585
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-012765. Epub 2021 May 03.

BACKGROUND AND OBJECTIVES: Routine human papillomavirus (HPV) vaccination is recommended at ages 11 to 12 years and may be initiated as early as 9 years of age.METHODS: Data were derived from the National Immunization Survey-Teen, spanning 2008-2018. Using health...

Cite
Chido-Amajuoyi OG, Talluri R, Wonodi C, et al. Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018. Pediatrics. 2021;147(6)doi: 10.1542/peds.2020-012765.
Chido-Amajuoyi, O. G., Talluri, R., Wonodi, C., & Shete, S. (2021). Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018. Pediatrics, 147(6), . https://doi.org/10.1542/peds.2020-012765
Chido-Amajuoyi, Onyema Greg, et al. "Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018." Pediatrics vol. 147,6 (2021). doi: https://doi.org/10.1542/peds.2020-012765
Chido-Amajuoyi OG, Talluri R, Wonodi C, Shete S. Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018. Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-012765. Epub 2021 May 03. PMID: 33941585.
Copy Download .nbib Format: NLM
Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019.

JAMA pediatrics

Chido-Amajuoyi OG, Talluri R, Shete SS, Shete S.
PMID: 34180965
JAMA Pediatr. 2021 Oct 01;175(10):1074-1076. doi: 10.1001/jamapediatrics.2021.1585.

No abstract available.

Cite
Chido-Amajuoyi OG, Talluri R, Shete SS, et al. Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019. JAMA Pediatr. 2021;175(10):1074-1076doi: 10.1001/jamapediatrics.2021.1585.
Chido-Amajuoyi, O. G., Talluri, R., Shete, S. S., & Shete, S. (2021). Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019. JAMA pediatrics, 175(10), 1074-1076. https://doi.org/10.1001/jamapediatrics.2021.1585
Chido-Amajuoyi, Onyema Greg, et al. "Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019." JAMA pediatrics vol. 175,10 (2021): 1074-1076. doi: https://doi.org/10.1001/jamapediatrics.2021.1585
Chido-Amajuoyi OG, Talluri R, Shete SS, Shete S. Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey-Teen, 2008 to 2019. JAMA Pediatr. 2021 Oct 01;175(10):1074-1076. doi: 10.1001/jamapediatrics.2021.1585. PMID: 34180965; PMCID: PMC8240004.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries